{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-025482","form_type":"8-K","ticker":"ULBI","cik":"0000875657","company_name":"ULTRALIFE CORP","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.542148+00:00","generated_at":"2026-05-17T18:42:42.661147+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ultralife Q2 revenue up 13% to $48.6M on Electrochem; margin down, GAAP EPS $0.05 vs $0.18","bullets":["Sales $48.6M (+13% YoY); organic Battery & Energy flat, Communications Systems down 57.2% to $2.7M.","Gross margin fell to 23.9% from 26.9% due to product mix, tariffs, and lower factory throughput.","Operating income $2.3M vs $3.9M; GAAP EPS $0.05 vs $0.18; adjusted EPS $0.07 vs $0.22.","Backlog with high-confidence orders $89M vs $95M at Q1 2025; debt prepaid $2.7M.","CEO expects improved results in H2 2025 on rebound in Communications and new product orders."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-025482","json":"https://secwatch.observer/filing/0001437749-25-025482.json","markdown":"https://secwatch.observer/filing/0001437749-25-025482.md","text":"https://secwatch.observer/filing/0001437749-25-025482.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/875657/000143774925025482/0001437749-25-025482-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/875657/000143774925025482/ulbi20250806_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:42:42.661147+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}